Advertisement

Loading...

IntelGenx Technologies Corp.

IGX.TOTSX
Healthcare
Biotechnology
$0.24
$0.04(17.07%)
Canadian Market is Open • 15:59

IntelGenx Technologies Corp. Fundamental Analysis

IntelGenx Technologies Corp. (IGX.TO) shows weak financial fundamentals with a PE ratio of -3.03, profit margin of -9.55%, and ROE of 1.27%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.04

Areas of Concern

ROE1.27%
Operating Margin-9.13%
Current Ratio0.41
We analyze IGX.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -827.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-827.4/100

We analyze IGX.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

IGX.TO struggles to generate sufficient returns from assets.

ROA > 10%
-1.20%

Valuation Score

Excellent

IGX.TO trades at attractive valuation levels.

PE < 25
-3.03
PEG Ratio < 2
-0.04

Growth Score

Weak

IGX.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IGX.TO shows balanced financial health with some risks.

Debt/Equity < 1
-1.27
Current Ratio > 1
0.41

Profitability Score

Weak

IGX.TO struggles to sustain strong margins.

ROE > 15%
126.70%
Net Margin ≥ 15%
-9.55%
Positive Free Cash Flow
No

Key Financial Metrics

Is IGX.TO Expensive or Cheap?

P/E Ratio

IGX.TO trades at -3.03 times earnings. This suggests potential undervaluation.

-3.03

PEG Ratio

When adjusting for growth, IGX.TO's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values IntelGenx Technologies Corp. at -2.46 times its book value. This may indicate undervaluation.

-2.46

EV/EBITDA

Enterprise value stands at -2.24 times EBITDA. This is generally considered low.

-2.24

How Well Does IGX.TO Make Money?

Net Profit Margin

For every $100 in sales, IntelGenx Technologies Corp. keeps $-9.55 as profit after all expenses.

-9.55%

Operating Margin

Core operations generate -9.13 in profit for every $100 in revenue, before interest and taxes.

-9.13%

ROE

Management delivers $1.27 in profit for every $100 of shareholder equity.

1.27%

ROA

IntelGenx Technologies Corp. generates $-1.20 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.20%

Following the Money - Real Cash Generation

Operating Cash Flow

IntelGenx Technologies Corp. generates limited operating cash flow of $-6.53M, signaling weaker underlying cash strength.

$-6.53M

Free Cash Flow

IntelGenx Technologies Corp. generates weak or negative free cash flow of $-6.71M, restricting financial flexibility.

$-6.71M

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

IGX.TO converts -22.27% of its market value into free cash.

-22.27%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.03

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

28.95

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.27

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.27

vs 25 benchmark

ROA

Return on assets percentage

-1.20

vs 25 benchmark

ROCE

Return on capital employed

67.31

vs 25 benchmark

How IGX.TO Stacks Against Its Sector Peers

MetricIGX.TO ValueSector AveragePerformance
P/E Ratio-3.0327.91 Better (Cheaper)
ROE126.70%687.00% Weak
Net Margin-955.44%-45285.00% (disorted) Weak
Debt/Equity-1.270.33 Strong (Low Leverage)
Current Ratio0.412795.76 Weak Liquidity
ROA-119.86%-13557.00% (disorted) Weak

IGX.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IntelGenx Technologies Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ